BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $94.20 Average PT from Brokerages

Published on December 25, 2024

Avoro Capital Advisors LLC lifted its holdings in shares of BioMarin Pharmaceutical by 4.4% during the second quarter. Avoro Capital

Continue reading on website
Other news

Super valuable content! A summary of the highlights from the 7th Alpha Summit by Wall Street Insights

December 25, 2024
重 two 新，" there are investment opportunities, profit opportunities, and valuation enhancement opportunities. Regardless of whether one is

Govt committed to improve quality spending, cut fiscal deficit to 4.5 pc in FY26: Finmin report

December 25, 2024
cent of BE.Taking into account the grant for creation of capital assets, the effective capital expenditure (Capex) was projected at Rs 15.